BlackRock Investment Management’s Barclays Bank Plc BCS.PRD.CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
$332K Hold
13,000
﹤0.01% 3144
2016
Q3
$338K Hold
13,000
﹤0.01% 3156
2016
Q2
$336K Hold
13,000
﹤0.01% 3204
2016
Q1
$340K Hold
13,000
﹤0.01% 3040
2015
Q4
$345K Hold
13,000
﹤0.01% 3126
2015
Q3
$336K Hold
13,000
﹤0.01% 3149
2015
Q2
$338K Hold
13,000
﹤0.01% 3213
2015
Q1
$341K Hold
13,000
﹤0.01% 3094
2014
Q4
$339K Hold
13,000
﹤0.01% 3154
2014
Q3
$338K Sell
13,000
-12,000
-48% -$311K ﹤0.01% 3145
2014
Q2
$647K Sell
25,000
-1,240
-5% -$32.1K ﹤0.01% 2896
2014
Q1
$683K Buy
26,240
+1,215
+5% +$31.2K ﹤0.01% 2782
2013
Q4
$635K Buy
25,025
+6
+0% +$153 ﹤0.01% 2824
2013
Q3
$636K Buy
25,019
+19
+0.1% +$482 ﹤0.01% 2762
2013
Q2
$633K Buy
+25,000
New +$640K ﹤0.01% 2692

Other funds holding BCS.PRD.CL

BlackRock Investment Management's BCS.PRD.CL Position: Q4 2016 in Review

BlackRock Investment Management held its Barclays Bank Plc (BCS.PRD.CL) position steady in Q4 2016 at 13,000 shares worth $332K. The position accounts for ﹤0.01% of the portfolio, ranked #3144.

BlackRock Investment Management first reported a position in BCS.PRD.CL in Q2 2013 and has held it in 15 quarters since. The position peaked at $683K in Q1 2014. 102 funds tracked by Wall St. Rank hold BCS.PRD.CL as of Q4 2016.

  • BlackRock Investment Management held 13,000 shares of Barclays Bank Plc worth $332K as of Q4 2016.
  • BlackRock Investment Management left its Barclays Bank Plc share count unchanged in Q4 2016.
  • Barclays Bank Plc made up ﹤0.01% of BlackRock Investment Management's portfolio in Q4 2016, its #3144 holding.
  • BlackRock Investment Management first reported a position in Barclays Bank Plc in Q2 2013 and has held it in 15 quarters since.
  • BlackRock Investment Management's Barclays Bank Plc position peaked at $683K in Q1 2014.
  • 102 funds tracked by Wall St. Rank held Barclays Bank Plc as of Q4 2016.

Based on BlackRock Investment Management's 13F filing for Q4 2016, filed 10 Feb 2017.